OMTHERA PHARMACEUTICALS INC

Inactive Instrument

Omthera Pharmaceuticals Inc Share Price

Equities

US68217A1034

Pharmaceuticals

End-of-day quote Nasdaq Other stock markets
- ^USD	-

2013	Novartis AG : AstraZeneca buys U.S. lung drug firm Pearl for up to $1.15 billion	RE
2013	Novartis AG : AstraZeneca buys U.S. lung drug firm Pearl for up to $1.15 billion	RE

on all our subscriptions*

Take advantage of the offer

* See conditions on site

Latest news about Omthera Pharmaceuticals Inc

Novartis AG : AstraZeneca buys U.S. lung drug firm Pearl for up to $1.15 billion	10/06/13	RE
Novartis AG : AstraZeneca buys U.S. lung drug firm Pearl for up to $1.15 billion	10/06/13	RE
GlaxoSmithKline plc : GSK bets on chimp virus with $321 million vaccines buy	29/05/13	RE
AstraZeneca plc : AstraZeneca buys heart firm Omthera for up to $443 million	28/05/13	RE
AstraZeneca plc : AstraZeneca buys heart firm Omthera for up to $443 million	28/05/13	RE

Press releases Omthera Pharmaceuticals Inc

Omthera Pharmaceuticals Inc : FDA accepts new drug application for investigational compound Epanova for the treatment of severe hypertriglyceridaemia	20/09/13	PU
Omthera Pharmaceuticals Inc : Omthera Stockholders Approve Acquisition by AstraZeneca	16/07/13	PR
Omthera Pharmaceuticals Inc : Omthera Pharmaceuticals Announces NDA Submission for Epanova(TM) for the Treatment of Patients with Very High Triglycerides	09/07/13	PR
Omthera Pharmaceuticals Inc : Omthera Pharmaceuticals Announces Termination Of Antitrust Waiting Period	27/06/13	PR
Omthera Pharmaceuticals Inc : Omthera Pharmaceuticals Announces Record Date and Meeting Date for Special Meeting of Stockholders	13/06/13	PR

More press releases

News in other languages on Omthera Pharmaceuticals Inc

Banques et statistiques ont soutenu Wall Street	28/05/13
Les valeurs à suivre aujourd'hui à Wall Street	28/05/13
Omthera Pharmaceuticals Inc : OMTHERA racheté par AstraZeneca	28/05/13

Company Profile

Sector

Pharmaceuticals

More about the company

Sector Specialty & Advanced Pharmaceuticals

	1st Jan change	Capi.
MERCK KGAA	+15.82%	78.51B
KYOWA KIRIN CO. LTD.	+13.10%	9B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.	+58.17%	4.96B
SK BIOPHARMACEUTICALS CO., LTD.	-14.94%	4.84B
YUHAN CORPORATION	-.--%	3.72B
INDIVIOR PLC	+19.49%	2.48B
BETTA PHARMACEUTICALS CO., LTD.	-26.63%	2.19B
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.	+16.75%	2.12B
CHANGCHUN BCHT BIOTECHNOLOGY CO.	-37.97%	1.94B

Specialty & Advanced Pharmaceuticals

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

BENEFIT NOW